Huron Consulting Group Inc.

Huron Consulting Group Inc. (HURN) Market Cap

Huron Consulting Group Inc. has a market capitalization of .

No quote data available.

CEO: Mark Hussey

Sector: Industrials

Industry: Consulting Services

IPO Date: 2004-10-13

Website: https://www.huronconsultinggroup.com

Huron Consulting Group Inc. (HURN) - Company Information

Market Cap: -|Sector: Industrials

Company Profile

Huron Consulting Group Inc. provides global professional services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The company offers financial and operational performance improvement consulting services; digital services; spanning technology and analytic-related services, including enterprise health record, enterprise resource planning, enterprise performance management, customer relationship management, data management, artificial intelligence and automation, technology managed services, and a portfolio of software products; organizational transformation; revenue cycle managed services and outsourcing; financial and capital advisory consulting; and strategy and innovation consulting. It also provides research-focused consulting and managed services, as well as Huron Research product suite, a software suite designed to facilitate and improve research administration service delivery and compliance. In addition, the company offers software products, financial capital advisory services, regulatory compliance and risk management consulting, and Commercial consulting. The company serves healthcare, education, financial services, industrials and manufacturing, energy and utilities, public sector, and other commercial industries. The company was incorporated in 2002 and is headquartered in Chicago, Illinois.

Analyst Sentiment

87%
Strong Buy

From 5 Active Polls

1Y Forecast: $176.00

▲ +0.0% Potential Upside

Consensus Target Metrics

Low Bound

$155

Median

$160

High Bound

$213

Average

$176

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$176.00
▲ +15.96% Upside
Low Target
$155.00
2% Risk
Median Target
$160.00
5% Mid
High Target
$213.00
40% Max

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

Sentiment volume allocation data unavailable.

Historical valuation matrix unavailable.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 HURON CONSULTING GROUP INC (HURN) — Investment Overview

🧩 Business Model Overview

Huron Consulting Group provides specialized consulting services that sit close to operational workflows in complex, regulated environments—most notably healthcare revenue cycle and provider operations, along with adjacent work in legal, education, and analytics-enabled business transformation. The value chain is typically: (1) diagnose process and data issues inside the client’s operating environment, (2) design workflow and technology-enabled operating models, (3) implement process changes using a mix of consulting talent, client resources, and technology tools, and (4) sustain performance through managed services and ongoing advisory support.

Client stickiness is driven by the fact that engagements often require deep integration with the client’s systems, reporting cadence, and operational governance. Deliverables commonly transition from strategy into day-to-day execution processes, making follow-on work and multi-year programs more likely than purely transactional, one-off projects.

💰 Revenue Streams & Monetisation Model

Revenue is generated primarily through fee-based consulting engagements, typically structured as time-and-materials, fixed-fee milestones, or outcome-linked transformation work. A meaningful portion also comes from longer-cycle initiatives that incorporate analytics, process redesign, and managed services—creating a more recurring revenue profile than generic “staff augmentation” models.

Margin drivers are largely tied to (1) utilization and billable rate discipline, (2) the mix between strategy-only advisory versus implementation/managed services (implementation tends to support steadier workstreams once embedded), and (3) the scaling of reusable methods and delivery accelerators that reduce incremental cost per project. Unlike software pure-plays, monetisation remains services-led, so operating leverage depends on maintaining bench strength while sustaining demand for specialized transformations.

🧠 Competitive Advantages & Market Positioning

Huron’s moat is best characterized as switching costs and intangible assets (deep domain expertise and delivery know-how), rather than proprietary network effects. Once a client’s teams adopt new revenue cycle workflows, governance processes, and analytics definitions, replacing the provider becomes operationally costly. Competitors also face barriers in replicating the combination of industry context, workflow integration, and the practical “how-to” of implementation.

  • Switching costs (workflow + system integration): Transformations often require mapping and re-architecting end-to-end processes (coding, denials, documentation, reporting) and aligning with payer/payment realities. Embedded staff training, performance baselines, and operational cadence create friction to switching vendors.
  • Intangible assets (domain expertise + repeatable delivery IP): Years of experience in healthcare operational pain points build a knowledge base that improves execution speed and reduces rework.
  • Client relationships in regulated decision cycles: Healthcare providers operate under compliance and reimbursement constraints; vendor selection tends to be conservative, favoring proven delivery partners.

Competitive benchmarking (primary peers):

  • Guidehouse (healthcare and government-focused consulting): broader presence across regulated sectors; competes on scale and cross-industry capabilities.
  • Deloitte (global professional services): strong brand and end-to-end transformation portfolio; often competes for large enterprise programs with broader offerings.
  • Accenture (technology and operations consulting): competes using large delivery ecosystems and technology-led transformation.

Huron differentiates through a more specialized focus on healthcare and operational workflows, with delivery tied to measurable performance in complex processes. In contrast, large diversified firms tend to approach similar problems from broader strategy/technology angles, which can increase the risk of less tailored execution if specialized domain depth is not prioritized.

🚀 Multi-Year Growth Drivers

The structural demand outlook for specialized consulting and analytics-enabled transformation supports a multi-year runway driven by:

  • Healthcare operational efficiency needs: Continued pressure to reduce revenue leakage, improve coding and claim quality, and manage administrative cost burdens sustains demand for revenue cycle and performance improvement programs.
  • Regulatory and payer complexity: Ongoing reimbursement rule changes and documentation requirements increase the need for specialized process and analytics capabilities.
  • Data-driven operations and analytics adoption: Clients move toward more standardized metrics, automation-assisted workflows, and decision support—areas where experienced domain implementation partners can command engagement extensions.
  • Managed services and long-cycle delivery: Once operating models are redesigned, clients often continue work through ongoing governance, monitoring, and continuous improvement—supporting a more durable revenue base than short engagements alone.
  • Expansion within existing accounts: Deep process understanding and established performance baselines can enable additional work across related operational domains (e.g., analytics, compliance support, and adjacent transformation streams).

Over a 5–10 year horizon, the total addressable market for operational transformation in healthcare remains sizable due to persistent administrative complexity, the shift toward performance accountability, and sustained investment in workflow modernization.

⚠ Risk Factors to Monitor

  • Talent and utilization risk: Services profitability depends on maintaining billable capacity and effective staffing. If demand softens, margins can compress due to utilization pressure.
  • Client budget and timing risk: Transformation programs can be delayed when providers face financial stress, payor uncertainty, or reprioritization of capital and operating spend.
  • Execution risk in complex transformations: Underperforming on implementation can lead to contract amendments, scope disputes, or lost expansion opportunities.
  • Competitive pressure and commoditization: Larger firms with scale and bundled offerings can bid aggressively, particularly in “strategy plus generic implementation” workstreams.
  • Regulatory and technology change: Shifts in healthcare compliance expectations or technology standards can require rapid method updates; lag can reduce delivery effectiveness.
  • Data security and privacy: Healthcare-related engagements involve sensitive information; cybersecurity and compliance failures can create material reputational and legal exposure.

📊 Valuation & Market View

Equity markets typically value specialized consulting firms using earnings-based multiples (e.g., EV/EBITDA or P/E frameworks) with a strong emphasis on business quality metrics: revenue durability, operating margin structure, utilization trends, and the stability of repeatable revenue streams (managed services and ongoing advisory).

Key valuation swing factors include: (1) the ability to sustain utilization and billable rate discipline, (2) mix shift toward longer-cycle work and managed services, (3) integration success in growth initiatives, and (4) resilience of demand in regulated, efficiency-driven segments.

🔍 Investment Takeaway

Huron presents a credible long-term thesis as a specialized consulting partner with structural client stickiness rooted in switching costs from embedded workflow/process transformation and intangible assets built through domain expertise in regulated healthcare operations. Multi-year demand drivers—administrative complexity, revenue leakage reduction, and analytics-enabled operational modernization—support continued engagement depth and account expansion, provided execution quality and staffing discipline remain consistent.


⚠ AI-generated — informational only. Validate using filings before investing.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-06-30

"Herc Holdings (HURN) reported Q2 2026 results with Revenue of $475.0M and Net Income of $31.2M (EPS $1.93). Revenue grew +5.2% QoQ (from $451.8M in Q1 2026) and +18.1% YoY (from $402.5M in Q2 2025). Net Income increased +34.4% QoQ (from $23.2M) and +60.8% YoY (from $19.4M). Profitability improved sequentially: operating margin rose to ~10.6% in Q2 from ~9.2% in Q1, while net margin climbed to ~6.6% from ~5.1%. Margins have also been trending higher versus the prior year (net margin ~4.8% in Q2 2025). Cash flow quality appears solid in Q2: operating cash flow was $120.5M and free cash flow was $121.4M, supported by a large working-capital swing. Capital intensity is modest (CapEx ~-$5.2M). Shareholder returns are supported by buybacks: the company repurchased stock for about $153M in the quarter, while no dividends were paid. Balance-sheet resilience improved versus Q1: total assets rose to $1.64B, equity was stable near $385M, and leverage looks materially lower in the latest quarter (net debt down sharply vs the prior quarter). For total return, price performance is weak (1Y change -8.7%), which limits the shareholder return score despite buybacks."

Revenue Growth

Good

Revenue increased +5.2% QoQ to $475.0M and +18.1% YoY versus $402.5M in Q2 2025, indicating healthy demand/volume and/or pricing.

Profitability

Positive

Net income rose +34.4% QoQ and +60.8% YoY. Net margin expanded to ~6.6% (from ~5.1% in Q1), and operating margin improved to ~10.6%.

Cash Flow Quality

Positive

Q2 operating cash flow was $120.5M with free cash flow of $121.4M. No dividends were paid; buybacks were meaningful, suggesting cash generation supported capital returns.

Leverage & Balance Sheet

Neutral

Total assets increased to $1.64B and equity was broadly stable (~$385M). Leverage improved sharply versus Q1 (net debt down to ~$20.5M from ~$861.0M), indicating reduced balance-sheet stress.

Shareholder Returns

Fair

Buybacks were strong in the quarter (~$153M). However, stock performance is negative over 1Y (-8.7%), so total shareholder return is mixed.

Analyst Sentiment & Valuation

Neutral

Price is $129.17 versus a consensus target of ~$157.5 (implied upside ~22%). Valuation appears reasonable given earnings support, though sentiment is not reflected by the 1Y price trend.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Huron delivered another quarter of accelerating momentum, with record RBR of $465.6m (+15.7% y/y; +10.8% organic) and margin expansion that translated into stronger earnings. Adjusted EBITDA rose to $72.6m (15.6% of RBR), improving 50 bps versus last year, while adjusted EPS grew 30.2% to $2.46. The core story is Healthcare-led recurring/outcomes-based managed services, including a 64% Q2 managed services growth rate (43% organic), reinforced by continued digital/AI mix shift. Guidance was raised and narrowed: FY 2026 RBR $1.85b–$1.89b, adjusted EBITDA margin 14.5%–15.0% (50 bps higher at the midpoint), and adjusted EPS $9.00–$9.40 (+17% at the midpoint). Management also quantified RelateCare (closed June 3) at ~$30m incremental 2026 RBR and ~$0.10 adjusted EPS accretion. Near-term focus is capacity management around high utilization and outcomes delivery, with tax and healthcare cost/regulatory dynamics remaining key sensitivities.

AI IconGrowth Catalysts

  • Organic RBR acceleration: total organic RBR growth of 10.8% in Q2; management highlighted improving RBR trajectory in the first half and acceleration in Q2
  • Healthcare managed services momentum: Healthcare RBR +17.4% and managed services growth +64% y/y in Q2 (43% organic), supporting recurring, outcomes-based revenue
  • AI-enabled digital mix shift: total digital bookings in 1H 2026 up more than 20% y/y; >60% of digital bookings have direct AI scope or delivery materially enabled by AI (vs ~35% in 1H 2025)
  • Clinical intelligent automation: time to recommendations compressed to hours vs days/weeks, driving faster implementation opportunities and margin/revenue expansion

Business Development

  • RelateCare acquisition (closed June 3): expected to add ~$30 million RBR in 2026; accretive to 2026 adjusted EPS by ~$0.10
  • Acquired Eclipse Insights and Axiom contributing incremental Healthcare RBR in Q2 (listed by CFO as ~$10.1 million total incremental RBR from acquisitions)
  • Acquired Treliant and Wilson Perumal contributing incremental Commercial RBR in Q2 (listed by CFO as ~$9.2 million incremental RBR)
  • Technology partners referenced for AI-enabled offerings: Anthropic, Microsoft, AWS

AI IconFinancial Highlights

  • Record Q2 2026 RBR: $465.6m, +15.7% y/y (and +10.8% organic RBR)
  • Net income: $31.2m ($1.91 diluted EPS) vs $19.4m ($1.09) in Q2 2025; net income as % of total revenues increased to 6.6% from 4.7%
  • Adjusted EBITDA: $72.6m, 15.6% of RBR vs $60.6m, 15.1% of RBR (margin expansion +50 bps)
  • Adjusted EPS: $2.46 vs $1.89 in Q2 2025; adjusted EPS growth +30.2% y/y
  • Effective tax rate: 27.2% in Q2 2026 (less favorable than statutory) driven by nondeductible items and inability to recognize certain foreign/capital loss benefits; full-year effective tax rate unchanged at 28%–30%
  • Segment operating income margins: Education +180 bps? (25.0% to 26.8% = +180 bps) and Commercial +440 bps (16.6% to 21.0%) while Healthcare remained relatively flat at 30.1%
  • DSO improved: 79 days in Q2 vs 82 days in Q1 (improvement attributed to collections timing on certain healthcare/education projects)

AI IconCapital Funding

  • Share repurchases: Q2 used $53.1m to repurchase ~438,000 shares; year-to-date repurchases $208.6m (~1.6m shares), ~9% of shares outstanding as of beginning of year
  • Cash and leverage: cash $31.2m; total debt $834m (senior bank debt); net debt $802.8m (net debt down $26.8m vs Q1 even after repurchases and acquisition payments)
  • Leverage ratio: 2.8x adjusted EBITDA at June 30, 2026 vs 3.1x at March 31, 2026; target leverage 2.0x–2.5x by end of 2026

AI IconStrategy & Ops

  • Capacity/hiring posture: management indicates active market hiring; hiring ramps once utilization clears ~80% threshold; target utilization cited as upper 70% range
  • Headcount growth expectation: full-year headcount growth in consulting characterized as high single-digit % (with flexibility if needed in back half)
  • AI go-to-market approach: business-unit led, letting client relationships and each segment’s AI journey dictate whether AI is standalone or embedded within broader digital initiatives

AI IconMarket Outlook

  • FY 2026 guidance (increased and narrowed): RBR $1.85b–$1.89b (midpoint +12% vs FY 2025)
  • FY 2026 adjusted EBITDA margin: 14.5%–15.0% of RBR (midpoint +50 bps vs FY 2025)
  • FY 2026 adjusted non-GAAP EPS: $9.00–$9.40 (midpoint +17% vs FY 2025)
  • Segment guidance FY 2026: Healthcare RBR growth mid-teens; Healthcare operating income margin ~30%–32%; Education RBR growth mid- to upper single-digit; Education operating income margin 24%–26%; Commercial RBR low-teen growth; Commercial operating margin 19%–21%
  • RelateCare impact: ~$30m RBR in 2026; adjusted EBITDA for acquisition consistent with consolidated margin guidance; integration costs not expected to repeat in 2027; accretive to 2026 adjusted EPS by ~$0.10
  • Cash flow: FY free cash flow $180m–$220m (net of cash taxes and interest; excludes noncash stock compensation)
  • Share count: FY 2026 weighted avg diluted share count 16.6m–16.8m (reflects accelerated repurchases during 2026)

AI IconRisks & Headwinds

  • Healthcare regulatory impact: OBBBA legislation estimated to reduce federal health care spending by over $1 trillion over 10 years; while management expects demand tailwinds into 2027+, regulatory implementation timing and hospital/system adoption could affect near-term variability
  • Cost pressure vs reimbursements: management cited labor, supplies and pharmaceutical costs rising faster than reimbursements, which could increase client urgency but also introduces execution and pricing risk
  • Tax sensitivity: effective tax rate driven by nondeductible items and inability to recognize certain foreign/capital losses; volatility could affect earnings cadence (though full-year effective tax rate guidance remains 28%–30%)

Q&A: Analyst Interest

  • Topic: Utilization-driven hiring plans and capacity ramp timing: Management said they are still in market hiring and typically add headcount when utilization is above ~80%, while the target utilization range is upper 70%. They expect headcount growth to land in high single-digit percent for the year, with potential back-half adds.
  • Topic: AI demand go-to-market strategy and how AI projects enter the pipeline: Management described a client- and business-unit-led model where teams interpret each segment’s stage in the AI journey. AI work can be standalone (strategy/governance) or embedded within larger digital initiatives; timing and mix depend on client needs and relationships rather than a single motion.
  • Topic: Managed services differentiation, feature set, and growth ceiling: Management attributed strong managed services growth to an outcomes-based model tied to revenue-cycle expertise, supporting land-and-expand via point solutions. They cited 43% growth in Q2 and emphasized differentiation versus large providers; retention suggests resonance, with RelateCare extending the approach.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the HURN Q2 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
© 2026 Stock Market Info — Huron Consulting Group Inc. (HURN) Financial Profile